Global Stem Cell Umbilical Cord Blood Market Overview
As per MRFR analysis, the Stem Cell Umbilical Cord Blood Market Size was estimated at 9.3 (USD Billion) in 2022. The Stem Cell Umbilical Cord Blood Market Industry is expected to grow from 9.94(USD Billion) in 2023 to 18.2 (USD Billion) by 2032. The Stem Cell Umbilical Cord Blood Market CAGR (growth rate) is expected to be around 6.95% during the forecast period (2024 - 2032).
Key Stem Cell Umbilical Cord Blood Market Trends Highlighted
The Stem Cell Umbilical Cord Blood Market is anticipated to witness significant growth in the coming years, driven by factors such as increasing awareness of the potential of stem cells, advancements in cord blood banking technology and government initiatives to promote cord blood banking. The market is characterized by the presence of established players as well as emerging companies that are investing in research and development to enhance the quality and accessibility of cord blood banking services. Recent trends in the market include the adoption of automation and digitalization in cord blood banking processes, increased demand for private banking services, and the emergence of new applications of cord blood stem cells in regenerative medicine. Opportunities for market growth lie in expanding access to cord blood banking services in developing countries, exploring the potential of cord blood stem cells in treating a wider range of diseases and developing innovative cord blood-based therapies.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Stem Cell Umbilical Cord Blood Market Drivers
Increasing Demand for Stem Cell Therapies
Stem cell therapies have gained popularity as a solution to manage various diseases and disorders such as cancers, disorders of blood and immune deficiency diseases. Umbilical cord blood is a rich source of stem cells, which makes it a valuable resource for these therapies. As the demand for stem cell therapies continues to grow, so too will the demand for umbilical cord blood. The Stem Cell Umbilical Cord Blood Market Industry is expected to witness significant growth in the coming years, driven by the increasing demand for stem cell therapies.
Growing Awareness of the Benefits of Cord Blood Banking
Parents are becoming more aware of the advantages of cord blood banking by the day. Parents have the opportunity to store the umbilical cord blood of their child for possible future use or sale. As such, years from now if a disease or particular condition requires the use of the child's stem cells, the parents have the added advantage of opting for directed cord blood banking for better storage. More awareness of the benefits of cord blood banking is also expected to increase the market size of the Stem Cell Umbilical Cord Blood Market Industry in the forecast timeline.
Government Support for Stem Cell Research
Governments around the world are providing support for stem cell research. This support is helping to advance the development of stem cell therapies and is expected to drive growth in the Stem Cell Umbilical Cord Blood Market Industry.
Stem Cell Umbilical Cord Blood Market Segment Insights
Stem Cell Umbilical Cord Blood Market Storage Source Insights
The Stem Cell Umbilical Cord Blood Market is segmented based on storage source into public, private and related. Among these, the public storage source segment is expected to hold the largest market share during the forecast period. The growth of the public storage source segment can be attributed to the increasing number of public cord blood banks and the rising awareness of the benefits of cord blood banking. In 2023, the public storage source segment accounted for approximately 60% of the Stem Cell Umbilical Cord Blood Market revenue.The segment is expected to grow at a CAGR of 6.5% during the forecast period, reaching a market value of USD 11.2 billion by 2032. The growth of the segment can be attributed to the increasing number of public cord blood banks and the rising awareness of the benefits of cord blood banking. The private storage source segment is expected to witness significant growth during the forecast period. The growth of the segment can be attributed to the increasing number of private cord blood banks and the rising demand for cord blood banking services from high-net-worth individuals.The related storage source segment is expected to grow at a steady pace during the forecast period. The growth of the market can be attributed to the increasing number of cord blood banks, the rising awareness of the benefits of cord blood banking, and the development of new cord blood-based therapies.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Stem Cell Umbilical Cord Blood Market Application Insights
The application segment is a crucial aspect of the Stem Cell Umbilical Cord Blood Market, offering insights into the diverse applications of stem cell umbilical cord blood in various medical fields. Hematological disorders hold a significant share of the market, driven by the increasing prevalence of blood-related diseases such as leukemia and lymphoma. Metabolic diseases, including genetic disorders and enzyme deficiencies, represent another substantial segment, as stem cell umbilical cord blood offers potential treatment options. Immune system disorders, such as autoimmune diseases and immunodeficiencies, are also gaining traction due to the ability of stem cells to modulate immune responses.Neurological disorders, including spinal cord injuries and neurodegenerative diseases, present opportunities for stem cell-based therapies. Other applications, such as regenerative medicine and tissue engineering, are emerging areas with promising potential for growth. The Stem Cell Umbilical Cord Blood Market is projected to witness steady growth in the coming years, driven by advancements in stem cell research and increasing demand for novel therapies.
Stem Cell Umbilical Cord Blood Market Collection Source Insights
The Stem Cell Umbilical Cord Blood Market segmentation by Collection Source into Birth Centers, Hospital Nursery and Clinics provides valuable insights into the industry dynamics. In 2023, the Hospital Nursery segment held a dominant market share due to the high volume of births occurring in hospitals, leading to greater accessibility of cord blood collection. However, the Birth Center segment is projected to witness significant growth over the forecast period, owing to the increasing popularity of birthing centers as an alternative to traditional hospital settings.Clinics, on the other hand, are expected to maintain a steady market share, catering to specialized collection needs and offering personalized services. The market growth for these segments is driven by factors such as rising awareness about stem cell banking, technological advancements in collection and storage methods and government initiatives promoting cord blood banking.
Stem Cell Umbilical Cord Blood Market Global Market Size Insights
The market growth is attributed to the increasing prevalence of chronic diseases, rising demand for stem cell therapies, and growing awareness about the potential of umbilical cord blood stem cells. Additionally, government initiatives and support for stem cell research and advancements in stem cell technology are expected to drive market expansion. The market is segmented into public cord blood banks and private cord blood banks, with private cord blood banks holding a larger market share due to the rising demand for personalized stem cell therapies.
Stem Cell Umbilical Cord Blood Market Projected Growth Insights
The Stem Cell Umbilical Cord Blood Market is projected to grow from USD 3.1 billion in 2023 to USD 9.94 billion by 2032, exhibiting a CAGR of 14.5% during the forecast period. This growth can be attributed to the increasing prevalence of chronic diseases, rising demand for stem cell therapies, and growing awareness of the benefits of cord blood banking. Additionally, government initiatives and funding for stem cell research are furthering the market growth. The market is segmented into public cord blood banks and private cord blood banks. Public cord blood banks collect and store cord blood donations for use in research and transplantation, while private cord blood banks collect and store cord blood for the potential future use of the donor or their family members.The private cord blood banking segment is expected to witness significant growth due to the increasing number of high-net-worth individuals and the growing awareness of the potential benefits of cord blood banking.
Stem Cell Umbilical Cord Blood Market Regional Insights
The Stem Cell Umbilical Cord Blood Market is segmented into North America, Europe, APAC, South America and MEA. North America is expected to hold the largest market share in 2023 and is projected to continue its dominance throughout the forecast period. The growth in this region is attributed to factors such as the rising prevalence of chronic diseases, increasing awareness about stem cell therapies, and the presence of major market players. Europe is anticipated to be the second-largest market, followed by APAC. The growth in these regions is fueled by the increasing healthcare expenditure, advancements in medical technology, and government initiatives to promote stem cell research.South America and MEA are expected to witness steady growth in the coming years due to the rising demand for stem cell therapies and the increasing investment in healthcare infrastructure. The Stem Cell Umbilical Cord Blood Market is projected to reach a value of USD 18.2 billion by 2032, exhibiting a CAGR of 6.95% during the forecast period.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Stem Cell Umbilical Cord Blood Market Key Players And Competitive Insights
Major players in Stem Cell Umbilical Cord Blood Market industry are constantly striving to gain a competitive edge by investing in research and development, expanding their product portfolios, and entering into strategic partnerships and acquisitions. Leading Stem Cell Umbilical Cord Blood Market players are focusing on developing innovative products and services to meet the evolving needs of customers and address unmet medical needs. The Stem Cell Umbilical Cord Blood Market Competitive Landscape is characterized by intense competition among established players and emerging entrants.A leading company in the Stem Cell Umbilical Cord Blood Market is Cord Blood Registry, which is a provider of cord blood banking services. The company offers a range of services, including cord blood collection, processing, storage, and banking. Cord Blood Registry has a global presence and serves clients in over 50 countries. The company has a strong reputation for quality and safety and is accredited by the American Association of Blood Banks (AABB). Cord Blood Registry is committed to providing innovative and affordable cord blood banking services to families around the world.A competitor company in the Stem Cell Umbilical Cord Blood Market is Cryo-Cell International, which is a provider of cord blood and cord tissue banking services. The company offers a variety of services, including cord blood collection, processing, storage and banking. Cryo-Cell International has a global presence and serves clients in over 40 countries. The company has a strong reputation for quality and safety and is accredited by the AABB. Cryo-Cell International is committed to providing innovative and affordable cord blood banking services to families around the world.
Key Companies in the Stem Cell Umbilical Cord Blood Market Include
- Virtus Health
- DNAVision
- CryoSave Group
- ViaCord
- StemCyte
- Cordlife
- Future Health Biobank
- Cryo Stemcell
- Cord Blood Registry
- Beijing AngelCord Stem Cell Bank
- Halcyon Health
- Eurocord
- Stem Express
- CryoCell International
- FamilyCord
Stem Cell Umbilical Cord Blood Market Industry Developments
The Stem Cell Umbilical Cord Blood Market is anticipated to grow significantly over the forecast period, driven by increasing awareness about the potential therapeutic applications of stem cells, rising prevalence of chronic diseases, and technological advancements in stem cell processing and storage. The market is expected to witness notable growth in the Asia-Pacific region, attributed to the presence of a large population base, growing healthcare expenditure, and increasing research activities. Key players in the market are focusing on strategic collaborations, acquisitions, and product launches to expand their market presence and enhance their product offerings. Recent news developments include the approval of novel stem cell-based therapies for various diseases, such as the approval of cord blood-derived stem cells for treating sickle cell disease by the U.S. Food and Drug Administration (FDA).
Stem Cell Umbilical Cord Blood Market Segmentation Insights
Stem Cell Umbilical Cord Blood Market Storage Source Outlook
Stem Cell Umbilical Cord Blood Market Application Outlook
- Hematological Disorders
- Metabolic Diseases
- Immune System Disorders
- Neurological Disorders
- Other Applications
Stem Cell Umbilical Cord Blood Market Collection Source Outlook
- Birth Center
- Hospital Nursery
- Clinics
Stem Cell Umbilical Cord Blood Market Global Market Size Outlook
Stem Cell Umbilical Cord Blood Market Projected Growth Outlook
- USD 3.1 billion in 2032 with a CAGR of 14.5% from 2023 to 2032
Stem Cell Umbilical Cord Blood Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
9.3(USD Billion) |
| Market Size 2023 |
9.94(USD Billion) |
| Market Size 2032 |
18.2(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
6.95% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Virtus Health, DNAVision, CryoSave Group, ViaCord, StemCyte, Cordlife, Future Health Biobank, Cryo Stemcell, Cord Blood Registry, Beijing AngelCord Stem Cell Bank, Halcyon Health, Eurocord, Stem Express, CryoCell International, FamilyCord |
| Segments Covered |
Storage Source, Application, Collection Source, Global Market Size, Projected Growth, Regional |
| Key Market Opportunities |
Growing Prevalence of Cancer Expanding Applications in Regenerative Medicine Advances in Stem Cell Research Rising Awareness of Cord Blood Banking Technological Advancements |
| Key Market Dynamics |
Increasing childbirth rates Growing awareness of cord blood stem cells Advancements in stem cell therapies Expansion of public and private cord blood banks Government support and regulatory approvals. |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Stem Cell Umbilical Cord Blood Market is expected to be valued at 9.94 billion USD in 2023.
The Stem Cell Umbilical Cord Blood Market is expected to grow at a CAGR of 6.95% from 2024 to 2032.
North America is expected to hold the largest share of the Stem Cell Umbilical Cord Blood Market in 2032.
Stem cell umbilical cord blood is used in a variety of applications, including the treatment of blood diseases, immune disorders, and metabolic disorders.
Key competitors in the Stem Cell Umbilical Cord Blood Market include Cryo-Cell International, Inc., Cord Blood America, Inc. and StemCyte, Inc.
Growth drivers of the Stem Cell Umbilical Cord Blood Market include the increasing prevalence of chronic diseases, the rising demand for stem cell therapies, and the growing awareness of the benefits of stem cell banking.
Challenges facing the Stem Cell Umbilical Cord Blood Market include the high cost of stem cell banking, the lack of standardized regulations, and the ethical concerns surrounding stem cell research.
The Stem Cell Umbilical Cord Blood Market is expected to reach 18.2 billion USD by 2032.
Key trends in the Stem Cell Umbilical Cord Blood Market include the increasing use of stem cells in regenerative medicine, the development of new stem cell therapies, and the growing adoption of stem cell banking.
Opportunities for growth in the Stem Cell Umbilical Cord Blood Market include the expansion of stem cell research, the development of new stem cell-based therapies, and the increasing demand for stem cell banking.
